share_log

Matinas BioPharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition

SEC announcement ·  Sep 8, 2023 17:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more